Headline
The latest stories from AHA Today.
The AHA today urged the Drug Enforcement Administration to explicitly consider drug shortages when setting and adjusting aggregate production quotas, citing concern that the agency’s proposal to reduce 2020 production quotas for five opioid controlled substances would exacerbate shortages of…
The Centers for Medicare & Medicaid Services should require states that propose Medicaid work requirements and other demonstrations to project the cost of administering them, the Government Accountability Office said in a report released yesterday.
The Centers for Medicare & Medicaid Services today published its star ratings for 2020 Medicare Advantage and prescription drug plans.
The Centers for Disease Control and Prevention this week reported a record 2.5 million cases of chlamydia, gonorrhea and syphilis in the U.S. in 2018, including a 40% increase in syphilis among newborns.
The Centers for Medicare & Medicaid Services has updated its alternative payment model participation status tool for the 2019 Quality Payment Program, which identifies eligible clinicians who qualify as advanced APM participants based on Medicare Part B claims data through June.
The Department of Health and Human Services today released a guide to help clinicians who are contemplating or initiating a reduction in opioid dosage or discontinuation of long-term opioid therapy for chronic pain.
AHA President and CEO Rick Pollack today addressed the National Association of Health Services Executives at its annual educational conference in Washington, D.C., where he stressed the importance of advancing health equity in America.
As long advocated by the AHA, the Department of Health and Human Services today proposed modernizing the Stark Law on physician self-referral and the Anti-kickback Statute.
The AHA today submitted recommendations to the Health Resources and Services Administration in response to the agency’s Rural Access to Health Care Services Request for Information.
The California Office of Statewide Health Planning and Development recently released the nation’s first mandatory data on wholesale acquisition cost increases for prescription drugs.